LUCID DIAGNOSTICS ($LUCD) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of -$0.07 per share, beating estimates of -$0.08 by $0.01. The company also reported revenue of $1,260,000, missing estimates of $1,410,660 by $-150,660.
You can see Quiver Quantitative's $LUCD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LUCID DIAGNOSTICS Hedge Fund Activity
We have seen 56 institutional investors add shares of LUCID DIAGNOSTICS stock to their portfolio, and 27 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AWM INVESTMENT COMPANY, INC. removed 2,990,500 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,259,645
- GHISALLO CAPITAL MANAGEMENT LLC removed 2,960,066 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,226,471
- RUSSELL INVESTMENTS GROUP, LTD. added 1,573,481 shares (+15537.5%) to their portfolio in Q1 2026, for an estimated $1,809,503
- ALYESKA INVESTMENT GROUP, L.P. removed 1,383,116 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,507,596
- LUMINUS MANAGEMENT LLC removed 541,836 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $590,601
- RENAISSANCE TECHNOLOGIES LLC added 532,894 shares (+181.5%) to their portfolio in Q4 2025, for an estimated $580,854
- VANGUARD GROUP INC added 444,611 shares (+9.8%) to their portfolio in Q4 2025, for an estimated $484,625
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
LUCID DIAGNOSTICS Analyst Ratings
Wall Street analysts have issued reports on $LUCD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 12/10/2025
To track analyst ratings and price targets for LUCID DIAGNOSTICS, check out Quiver Quantitative's $LUCD forecast page.
LUCID DIAGNOSTICS Price Targets
Multiple analysts have issued price targets for $LUCD recently. We have seen 3 analysts offer price targets for $LUCD in the last 6 months, with a median target of $3.0.
Here are some recent targets:
- Edward Woo from Ascendiant Capital set a target price of $9.0 on 04/09/2026
- Mark Massaro from BTIG set a target price of $2.5 on 03/30/2026
- Mike Matson from Needham set a target price of $3.0 on 03/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
